Fidelity Investments
CNTB

Fidelity Investments’s Connect Biopharma Holdings CNTB Stock Holding History

Fidelity Investments’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$747 Buy
+314
New +$761 ﹤0.01% 5275
2024
Q1 		– Sell
-23
Closed -$28 – 5405
2023
Q4 		$27 Sell
23
-1
-4% -$1 ﹤0.01% 5132
2023
Q3 		$18 Hold
24
– – ﹤0.01% 5099
2023
Q2 		$26 Sell
24
-9
-27% -$10 ﹤0.01% 5125
2023
Q1 		$33 Sell
33
-50
-60% -$55 ﹤0.01% 5025
2022
Q4 		$72 Sell
83
-4
-5% -$3 ﹤0.01% 4909
2022
Q3 		$0 Sell
87
-97
-53% -$117 ﹤0.01% 4906
2022
Q2 		$0 Sell
184
-2,283,085
-100% -$3.36M ﹤0.01% 4968
2022
Q1 		$6.89M Sell
2,283,269
-1,134,295
-33% -$4.79M ﹤0.01% 2263
2021
Q4 		$17.6M Sell
3,417,564
-1,400,625
-29% -$15.6M ﹤0.01% 1890
2021
Q3 		$115M Buy
4,818,189
+892,353
+23% +$20.2M 0.01% 1038
2021
Q2 		$76.7M Buy
3,925,836
+740,847
+23% +$12.4M 0.01% 1240
2021
Q1 		$58.9M Buy
+3,184,989
New +$54.2M 0.01% 1315

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

Fidelity Investments's CNTB Position: Q2 2026 in Review

Fidelity Investments opened a new position in Connect Biopharma Holdings (CNTB) in Q2 2026: 314 shares worth $747. The stake represents ﹤0.01% of the portfolio and ranks #5275 among its holdings. This is a return to the name: Fidelity Investments previously reported a position in CNTB as recently as Q4 2023.

Fidelity Investments first reported a position in CNTB in Q1 2021 and has held it in 13 quarters since. The position peaked at $115M in Q3 2021. 56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • Fidelity Investments held 314 shares of Connect Biopharma Holdings worth $747 as of Q2 2026.
  • Connect Biopharma Holdings was a new Fidelity Investments position in Q2 2026.
  • Connect Biopharma Holdings made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5275 holding.
  • Fidelity Investments first reported a position in Connect Biopharma Holdings in Q1 2021 and has held it in 13 quarters since.
  • Fidelity Investments's Connect Biopharma Holdings position peaked at $115M in Q3 2021.
  • 56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.